Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Ewa Bodzenta"'
Autor:
Joanna Góra-Tybor, Aleksandra Gołos, Damian Mikulski, Grzegorz Helbig, Tomasz Sacha, Krzysztof Lewandowski, Joanna Niesiobędzka-Krężel, Maria Bieniaszewska, Hubert Wysogląd, Olga Grzybowska-Izydorczyk, Ilona Seferyńska, Marta Sobas, Maria Czyżewska, Agnieszka Michalska, Waldemar Sawicki, Malwina Mazur, Marek Hus, Ewa Bodzenta, Magdalena Olszewska-Szopa, Martyna Włodarczyk, Elżbieta Patkowska, Wojciech Świstek, Krzysztof Jamroziak
Publikováno v:
Clinical lymphoma, myelomaleukemia. 23(1)
Ruxolitinib is widely used in myelofibrosis (MF). However, some patients do not optimally respond and require more efficacious treatment. Our analysis aimed to establish predictors of ruxolitinib response.We designed a multicenter, retrospective anal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b94797833b4fefcc3b28a49efc769903
https://pubmed.ncbi.nlm.nih.gov/36396583
https://pubmed.ncbi.nlm.nih.gov/36396583
Autor:
Bartosz Pula, Ewa Bodzenta, Dorota Zdunczyk, Małgorzata Rydzanicz, Iwona Sokolowska-Giezgala, Katarzyna Warzybok, Marcin M Machnicki, Magdalena Olszewska-Szopa, Anna Labedz, Jolanta Wieczorek, Dominika Wisniewska-Organek, Tomasz Stoklosa, Kamila Kruczkowska-Tarantowicz, Krzysztof Jamroziak, Marek Dudziński, Zofia Spyra-Gorny, Rafał Płoski, Dariusz Kumorek, Monika Pepek, Alina Urbanowicz, Elzbieta Morawiec-Szymonik, Agnieszka Szeremet, Pawel Bernatowicz, Agnieszka Pollak, Ryszard Wichary, Waldemar Tomczak
Publikováno v:
Acta Haematologica Polonica. 52:94-102
Indtroduction and methods: In chronic lymphocytic leukemia (CLL), molecular and cytogenetic diagnostics are crucial for the determination of accurate prognosis and treatment choice. Among different genetic aberrations, del(17p13) or TP53 mutations co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b29c879af395808b51a5c434c9bb48bf
https://doi.org/10.5603/ahp.2021.0015
https://doi.org/10.5603/ahp.2021.0015
Autor:
Ilona Szypuła-Perkosz, Janusz Limon, Agnieszka Barchnicka, Sebastian Grosicki, Elżbieta Chachaj, Ewa Bodzenta, Bożena Jaźwiec
Publikováno v:
Hematologia. 8:152-158
This paper describes a case of 20 years old woman with acute promyelocytic leukemia who refused to accept blood transfusion because of religious beliefs. Individualized induction chemotherapy with daunorubicin, cladribine, cytarabine and all-trans re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::feab2c775bd70717d42f4acb727b3828
https://doi.org/10.5603/hem.2017.0018
https://doi.org/10.5603/hem.2017.0018
Autor:
Wanda Knopinska-Posluszny, Sebastian Grosicki, Agnieszka Piekarska, Grzegorz Helbig, Malgorzata Razny, Andrzej Hellman, Sebastian Giebel, Konrad Stępka, Ewa Lech-Marańda, Agnieszka Wierzbowska, Janusz Kloczko, Ewa Bodzenta, Magdalena Czemerska, Jerzy Holowiecki, Tomasz Wróbel, Mateusz Nowicki, Marta Sobas, Marek Hus, Kamil Brzozowski, Piotr Stelmach, Elżbieta Patkowska, Olga Grzybowska-Izydorczyk, Anna Szmigielska-Kapłon, Marta Kuydowicz, Ewa Wawrzyniak, Krzysztof Warzocha, Karol Wojcik, Anna Krawczynska, Tomasz Gromek, Lukasz Bolkun, Agnieszka Pluta, Tadeusz Robak
Publikováno v:
Leukemialymphoma. 61(3)
We present the results of a prospective, non-randomized phase 2 trial in which 253 AML patients (pts) under 60 years old received DAC (Daunorubicin + AraC + Cladribine) as first induction followed by CLAM (Cladribine + AraC + Mitoxantrone) as early s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::789860fd19f1b20ad333e554e14be3dc
https://pubmed.ncbi.nlm.nih.gov/31661339
https://pubmed.ncbi.nlm.nih.gov/31661339
Autor:
Waldemar Sawicki, Aleksandra Gołos, Malwina Mazur, Ewa Bodzenta, Ilona Seferynska, Magdalena Olszewska-Szopa, Marek Hus, Maria Czyżewska, Wojciech Świstek, Maria Bieniaszewska, Joanna Gora Tybor, Marta Sobas, Hubert Wysoglad, Joanna Niesiobedzka-Krezel, Agnieszka Michalska, Elżbieta Patkowska, Olga Grzybowska-Izydorczyk, Krzysztof Jamroziak, Krzysztof Lewandowski, Tomasz Sacha
Publikováno v:
Blood. 134:4180-4180
Background: Ruxolitinib (RUX), an inhibitor of JAK1/JAK2 kinases, is the only drug approved for the treatment of myelofibrosis (MF). The main clinical effects of RUX therapy include decrease of splenomegaly and reduction of burden of constitutional s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::622d4fca18f524195f202e80eeab2afd
https://doi.org/10.1182/blood-2019-125864
https://doi.org/10.1182/blood-2019-125864
Publikováno v:
Acta Haematologica Polonica. 46:172-173
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::413fadf5232ad49382ef8501b8283040
https://doi.org/10.1016/j.achaem.2015.07.292
https://doi.org/10.1016/j.achaem.2015.07.292
Autor:
Sebastian Grosicki, E. Patkowska, Marzena Wątek, I. Szypuła, A. Czyż, E. Ulenberg, Marcin Pasiarski, Ewa Bodzenta, Agnieszka Wierzbowska, Beata Piątkowska-Jakubas, Marta Kuydowicz, Monika Joks, K. Warzocha, Andrzej Hellmann
Publikováno v:
Acta Haematologica Polonica. 46:145-146
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::877715f604ac8d6af503cb584684724b
https://doi.org/10.1016/j.achaem.2015.07.339
https://doi.org/10.1016/j.achaem.2015.07.339
Publikováno v:
Journal of Leukemia.
A 20-year-old woman was admitted to our unit, because of pre-B acute lymphoblastic leukemia (ALL). Classical cytogenetics revealed a normal karyotype. In FISH analysis no TEL-AML1 fusion, rearranged MLL gene, or BCRABL were found. The induction and c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d206a49117da8cb0e961740eca101c70
https://doi.org/10.4172/2329-6917.1000102
https://doi.org/10.4172/2329-6917.1000102
Autor:
Ewa Bodzenta, M. Twardosz, M. Kriegler, M. Fejklowicz, Olga Haus, T. Kurzawa, A. Jaśkowiec, Sebastian Grosicki, A. Barchnicka, I. Szypuła
Publikováno v:
Acta Haematologica Polonica. 44:75-76
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70a6c810d29b9eb27b45d5ac67e6e864
https://doi.org/10.1016/j.achaem.2013.07.031
https://doi.org/10.1016/j.achaem.2013.07.031
Autor:
T. Kurzawa, M. Kriegler, M. Fejklowicz, M. Twardosz, Sebastian Grosicki, A. Melisz, A. Barchnicka, I. Szypuła, Ewa Bodzenta
Publikováno v:
Acta Haematologica Polonica. 44:76-77
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ffdd6999cd5515a74fd29ca82253c48
https://doi.org/10.1016/j.achaem.2013.07.032
https://doi.org/10.1016/j.achaem.2013.07.032